We’re thrilled to share that our Cohort 8.0 founder Garland Surgical has been awarded a grant from the West Midlands Health Tech Innovation Accelerator (WMHTIA).

This significant funding represents a major milestone in their journey toward the commercialisation of MaltaHip, the innovative ultra-low wear hip replacement designed specifically for younger, active patients.

With the support of the WMHTIA, which is funded by the Department for Science, Innovation and Technology in partnership with Innovate UK and the West Midlands Combined Authority, Garland will be able to accelerate their product rapidly. This grant will enable them to advance the development of MaltaHip, bringing them closer to offering a one-surgery solution that can improve the quality of life for countless individuals.

Share: Share on Twitter Share on LinkedIn

22 Jul 2026 | Cohort Successes

Chris Pinder, Founder of Accelerate Cohort 8.0's uControl attended Parliament for a discussion on...

Read Article SHARE Share on Twitter Share on LinkedIn

08 Jul 2026 | Cohort Successes

CEO Adrian Burden of BetaDen alumni BlockMark Technologies attended the formal launch of the Cyber...

Read Article SHARE Share on Twitter Share on LinkedIn

06 Jul 2026 | Cohort Successes

BetaDen Accelerate alumni Our Journey, Garland Surgical & CORZ have all been nominated for the 2026...

Read Article SHARE Share on Twitter Share on LinkedIn